Breaking News Instant updates and real-time market news.

DPLO

Diplomat Pharmacy

$21.45

0.24 (1.13%)

16:20
08/06/18
08/06
16:20
08/06/18
16:20

Diplomat Pharmacy cuts FY18 EPS view to (15c)-1c from 6c-17c, consensus 92c

Sees FY18 revenue $5.5B-$5.9B, consensus $5.67B. "Our EPS expectations assume approximately 74,300,000 weighted average common shares outstanding on a diluted basis and a tax rate of (5)% and 32%, for the low- and high-end of the range, respectively, for the full year 2018, each of which could differ materially. "

  • 06

    Aug

  • 13

    Sep

DPLO Diplomat Pharmacy
$21.45

0.24 (1.13%)

05/10/18
JPMS
05/10/18
UPGRADE
Target $27
JPMS
Overweight
Diplomat Pharmacy upgraded to Overweight with $27 target at JPMorgan
JPMorgan analyst Lisa Gill upgraded Diplomat Pharmacy to Overweight from Neutral and raised her price target for the shares to $27 from $24. The analyst sees opportunities for the company on the pharmacy benefits manager side of the business and believes Diplomat has the flexibility to pursue accretive acquisitions.
06/22/18
LEER
06/22/18
NO CHANGE
Target $33
LEER
Outperform
Diplomat Pharmacy price target raised to $33 from $27 at Leerink
Leerink analyst David Larsen raised his price target for Diplomat Pharmacy to $33 after hosting investor meetings with management. The analyst believes demand for Diplomat's pharmacy benefits manager CastiaRx is accelerating relative to previous years. Further, he thinks earnings potential from biosimilars, over the long run, may be greater than what he had been expecting. In addition, Larsen is "positively surprised" that the senior leadership team does not view President Trump's Blueprint plan as a significant risk. The analyst reiterates an Outperform rating on Diplomat Pharmacy.
06/28/18
JPMS
06/28/18
NO CHANGE
JPMS
Amazon deal creates significant overhang on Rx channel sentiment, says JPMorgan
JPMorgan Analyst Lisa Gill said Amazon's (AMZN) agreement to acquire PillPack is expected to drive a "significant overhang" on sentiment across the prescription channel, even though she doesn't expect PillPack to capture a material share of the market in the near term. While the deal establishes an initial foothold for Amazon in the mail pharmacy space, she thinks it will take time to scale up and she does not believe PillPack's unit dose packaging technology is unique. Gill also noted that Express Scripts (ESRX) said it would remove PillPack from its pharmacy network in 2016 on allegations it had misrepresented itself as a retail pharmacy and not a mail pharmacy, though within weeks PillPack was added back by the PBM. Shares of retail pharmacy operators CVS Health (CVS), Walgreens (WBA) and Rite Aid (RAD) have all been pressured by the news of Amazon's deal, as have the shares of drug distributors AmerisourceBergen (ABC), Cardinal Health (CAH) and McKesson (MCK). Diplomat Pharmacy (DPLO), an operator of a specialty pharmacy, is also sharply lower following the announcement from Amazon.
07/23/18
WBLR
07/23/18
NO CHANGE
WBLR
Outperform
Diplomat Pharmacy recent selloff overdone, says William Blair
William Blair analyst John Kreger attributes the 20% pullback in shares of Diplomat Pharmacy from the June highs to growing concerns about the company's exposure to pharmaceutical rebates, which the Trump administration is seeking to regulate as part of a broader effort to lower drug prices for consumers. The analyst views the recent selloff as overdone. The vast majority of Diplomat's newly acquired pharmacy benefit management business is with commercial clients, rather than from Medicaid or Medicare Part D, Kreger tells investors in a research note. As such, any new regulations out of the Trump administration would presumably not affect PBM dealings with commercial clients, at least not directly, the analyst adds. Further, the analyst notes that rebates are just one of three broad ways in which PBMs are compensated by their clients. The other two are administrative per-claim fees and spread pricing on dispensed prescriptions. If rebates become less popular, the economics of the business could quickly shift to other payment mechanisms such as higher per-claim fees, Kreger contends. He does not view regulation of drug rebates as a long-term threat to the economics of the PBM business model for Diplomat or its larger peers. The analyst keeps an Outperform rating on Diplomat Pharmacy.

TODAY'S FREE FLY STORIES

YEXT

Yext

$23.00

0.33 (1.46%)

22:43
03/18/19
03/18
22:43
03/18/19
22:43
Syndicate
Yext 6.1M share Spot Secondary priced at $21.50 »

Goldman Sachs is acting…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Mar

WU

Western Union

$18.17

-0.2 (-1.09%)

22:42
03/18/19
03/18
22:42
03/18/19
22:42
Hot Stocks
Western Union to partner with emerging-market moble network Thunes »

Western Union has teamed…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MYL

Mylan

$28.17

0.09 (0.32%)

22:40
03/18/19
03/18
22:40
03/18/19
22:40
Hot Stocks
Mylan conducts voluntary recall of Levoleucovorin Injection »

Mylan Institutional LLC…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TYHT

Shineco

$0.67

0.0003 (0.04%)

20:43
03/18/19
03/18
20:43
03/18/19
20:43
Recommendations
Shineco analyst commentary  »

Shineco establishing…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ATVI

Activision Blizzard

$44.97

0.33 (0.74%)

20:31
03/18/19
03/18
20:31
03/18/19
20:31
Hot Stocks
Activision Blizzard unveils Call of Duty: Mobile edition »

Activision, in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BA

Boeing

$372.10

-6.795 (-1.79%)

20:28
03/18/19
03/18
20:28
03/18/19
20:28
Hot Stocks
Boeing CEO says 'work progressing thoroughly' to understand cause for 737 crash »

In a letter, Boeing CEO…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Mar

  • 28

    May

GPX

GP Strategies

$12.57

-1.745 (-12.19%)

20:25
03/18/19
03/18
20:25
03/18/19
20:25
Recommendations
GP Strategies analyst commentary at Barrington »

GP Strategies organic…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Mar

MIK

Michaels

$11.79

0.11 (0.94%)

, DSW

DSW

$25.30

-0.09 (-0.35%)

20:25
03/18/19
03/18
20:25
03/18/19
20:25
Earnings
Notable companies reporting before tomorrow's open »

Notable companies…

MIK

Michaels

$11.79

0.11 (0.94%)

DSW

DSW

$25.30

-0.09 (-0.35%)

HDS

HD Supply

$43.09

0.09 (0.21%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Mar

  • 19

    Mar

  • 19

    Mar

  • 25

    Mar

  • 26

    Mar

  • 27

    Mar

NVDA

Nvidia

$168.91

-0.99 (-0.58%)

, AMZN

Amazon.com

$1,742.00

29.29 (1.71%)

20:19
03/18/19
03/18
20:19
03/18/19
20:19
Hot Stocks
Nvidia to partner with Amazon on bringing AI to connected devices »

NVIDIA (NVDA) announced a…

NVDA

Nvidia

$168.91

-0.99 (-0.58%)

AMZN

Amazon.com

$1,742.00

29.29 (1.71%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Mar

  • 19

    Mar

  • 20

    Mar

  • 26

    Mar

  • 04

    Apr

MEOH

Methanex

$57.22

1.68 (3.02%)

19:57
03/18/19
03/18
19:57
03/18/19
19:57
Hot Stocks
Methanex confirms M&G Investment letter, urges shareholders take no action »

Methanex confirms that it…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HDS

HD Supply

$43.09

0.09 (0.21%)

19:55
03/18/19
03/18
19:55
03/18/19
19:55
Earnings
HD Supply sees FY19 EPS $3.52-$3.81, consensus $3.64 »

Sees FY19 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Mar

  • 27

    Mar

HDS

HD Supply

$43.09

0.09 (0.21%)

19:53
03/18/19
03/18
19:53
03/18/19
19:53
Earnings
HD Supply sees Q1 EPS 75c-84c, consensus 85c »

Sees Q1 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Mar

  • 27

    Mar

HDS

HD Supply

$43.09

0.09 (0.21%)

19:52
03/18/19
03/18
19:52
03/18/19
19:52
Earnings
HD Supply reports Q4 adjusted EPS 70c, consensus 67c »

Reports Q4 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Mar

  • 27

    Mar

CASA

Casa Systems

$8.89

-0.06 (-0.67%)

19:47
03/18/19
03/18
19:47
03/18/19
19:47
Initiation
Casa Systems initiated at DA Davidson »

Casa Systems initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CCI

Crown Castle

$124.67

-0.41 (-0.33%)

19:46
03/18/19
03/18
19:46
03/18/19
19:46
Downgrade
Crown Castle rating change at Deutsche Bank »

Crown Castle downgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ARPO

Aerpio Pharmaceuticals

$1.22

-2.915 (-70.58%)

19:39
03/18/19
03/18
19:39
03/18/19
19:39
Downgrade
Aerpio Pharmaceuticals rating change at Guggenheim »

Aerpio Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Mar

LIVX

LiveXLive Media

$6.30

0.19 (3.11%)

19:37
03/18/19
03/18
19:37
03/18/19
19:37
Initiation
LiveXLive Media initiated at Maxim »

LiveXLive Media initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Mar

  • 30

    Apr

  • 01

    May

AKBA

Akebia

$8.19

0.01 (0.12%)

19:31
03/18/19
03/18
19:31
03/18/19
19:31
Recommendations
Akebia analyst commentary at Piper Jaffray »

Akebia investors should…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Mar

VALE

Vale

$13.28

0.11 (0.84%)

19:18
03/18/19
03/18
19:18
03/18/19
19:18
Periodicals
Vale to resume activities at port after court injunction, Reuters reports »

Vale said Friday that it…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Mar

TROX

Tronox

$12.09

0.2 (1.68%)

19:00
03/18/19
03/18
19:00
03/18/19
19:00
Hot Stocks
Tronox to present National Titanium Dioxide deal to FTC »

Tronox confirmed that its…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HYMTF

Hyundai Motor

$0.00

(0.00%)

, HYMLF

Hyundai Motor Co

$0.00

(0.00%)

18:58
03/18/19
03/18
18:58
03/18/19
18:58
Hot Stocks
Connecticut AG announces probe into Hyundai, Kia fires »

Connecticut Attorney…

HYMTF

Hyundai Motor

$0.00

(0.00%)

HYMLF

Hyundai Motor Co

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SYNH

Syneos Health

$47.42

0.49 (1.04%)

, TLRY

Tilray

$72.15

-0.38 (-0.52%)

18:54
03/18/19
03/18
18:54
03/18/19
18:54
Hot Stocks
Fly Intel: After Hours Movers »

UP AFTER EARNINGS: …

SYNH

Syneos Health

$47.42

0.49 (1.04%)

TLRY

Tilray

$72.15

-0.38 (-0.52%)

EOLS

Evolus

$23.80

-1.02 (-4.11%)

AMRS

Amyris

$3.83

-0.1 (-2.54%)

FOE

Ferro

$18.88

0.125 (0.67%)

REV

Revlon

$19.39

0.42 (2.21%)

AKBA

Akebia

$8.19

0.01 (0.12%)

TORC

ResTORbio

$8.97

0.27 (3.10%)

TACO

Del Taco

$10.60

0.47 (4.64%)

HQY

HealthEquity

$82.86

0.76 (0.93%)

CVTI

Covenant Transportation

$21.43

-0.4 (-1.83%)

YEXT

Yext

$23.00

0.33 (1.46%)

WAGE

WageWorks

$39.59

1.875 (4.97%)

TWO

Two Harbors

$14.26

0.07 (0.49%)

AGS

PlayAGS

$25.65

-0.89 (-3.35%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Mar

  • 18

    Mar

  • 18

    Mar

  • 18

    Mar

  • 18

    Mar

  • 18

    Mar

  • 18

    Mar

  • 18

    Mar

  • 18

    Mar

  • 19

    Mar

  • 19

    Mar

  • 21

    Mar

  • 17

    Apr

  • 16

    May

  • 19

    Mar

  • 19

    Mar

  • 19

    Mar

  • 20

    Mar

AAPL

Apple

$188.03

1.83 (0.98%)

18:52
03/18/19
03/18
18:52
03/18/19
18:52
Periodicals
Apple stops iOS 12.1.3 code signing after iOS 12.1.4 launch, AppleInsider says »

Apple has stopped signing…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WP

Worldpay

$108.52

9.8 (9.93%)

, FIS

FIS

$108.14

-0.73 (-0.67%)

18:41
03/18/19
03/18
18:41
03/18/19
18:41
Downgrade
Worldpay, FIS rating change at BMO Capital »

Worldpay downgraded to…

WP

Worldpay

$108.52

9.8 (9.93%)

FIS

FIS

$108.14

-0.73 (-0.67%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Mar

  • 18

    Mar

  • 19

    Mar

  • 26

    Mar

  • 27

    Mar

  • 28

    Mar

  • 04

    Apr

ERIC

Ericsson

$9.56

-0.075 (-0.78%)

18:32
03/18/19
03/18
18:32
03/18/19
18:32
Hot Stocks
Ericsson selected by TDC to roll out commercial 5G in Denmark »

Ericsson has been…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.